{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:17:44Z","timestamp":1770466664091,"version":"3.49.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00210-024-03347-6","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:02:57Z","timestamp":1722855777000},"page":"69-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Approaches based on natural products and miRNAs in pituitary adenomas: unveiling therapeutic intervention"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3884-831X","authenticated-orcid":false,"given":"Adel Mohamed","family":"Aboregela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"3347_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02280-5","volume":"21","author":"M Alavi","year":"2021","unstructured":"Alavi M, Farkhondeh T, Aschner M, Samarghandian S (2021) Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation. Cancer Cell Int 21:1\u20139","journal-title":"Cancer Cell Int"},{"key":"3347_CR2","doi-asserted-by":"crossref","first-page":"117955142093292","DOI":"10.1177\/1179551420932921","volume":"13","author":"MH AlMalki","year":"2020","unstructured":"AlMalki MH, Ahmad MM, Brema I, AlDahmani KM, Pervez N, Al-Dandan S, AlObaid A, Beshyah SA (2020) Contemporary management of clinically non-functioning pituitary adenomas: a clinical review. Clin Med insights Endocrinol Diab 13:1179551420932921","journal-title":"Clin Med insights Endocrinol Diab"},{"key":"3347_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12935-022-02677-w","volume":"22","author":"P Asgharian","year":"2022","unstructured":"Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V (2022) Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int 22:257","journal-title":"Cancer Cell Int"},{"key":"3347_CR4","doi-asserted-by":"crossref","first-page":"e9893","DOI":"10.1371\/journal.pone.0009893","volume":"5","author":"MLY Bangaru","year":"2010","unstructured":"Bangaru MLY, Woodliff J, Raff H, Kansra S (2010) Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing\u2019s disease. PLoS One 5:e9893","journal-title":"PLoS One"},{"key":"3347_CR5","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.3390\/ijms21197287","volume":"21","author":"O Beylerli","year":"2020","unstructured":"Beylerli O, Beeraka NM, Gareev I, Pavlov V, Yang G, Liang Y, Aliev G (2020) MiRNAs as noninvasive biomarkers and therapeutic agents of pituitary adenomas. Int J Mol Sci 21:7287","journal-title":"Int J Mol Sci"},{"key":"3347_CR6","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.2174\/1568026619666181120121830","volume":"18","author":"S Biswas","year":"2018","unstructured":"Biswas S (2018) MicroRNAs as therapeutic agents: the future of the battle against cancer. Curr Top Med Chem 18:2544\u20132554","journal-title":"Curr Top Med Chem"},{"key":"3347_CR7","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/ijc.33268","volume":"147","author":"E-M Bogner","year":"2020","unstructured":"Bogner E-M, Daly AF, Gulde S, Karhu A, Irmler M, Beckers J, Mohr H, Beckers A, Pellegata NS (2020) miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance. Int J Cancer 147:3523\u20133538","journal-title":"Int J Cancer"},{"key":"3347_CR8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11596-022-2568-6","volume":"42","author":"Z Cai","year":"2022","unstructured":"Cai Z, Qian B, Pang J, Tan ZB, Zhao K, Lei T (2022) Celastrol induces apoptosis and autophagy via the AKT\/mTOR signaling pathway in the pituitary ACTH-secreting adenoma cells. Curr Med Sci 42:387\u2013396","journal-title":"Curr Med Sci"},{"key":"3347_CR9","doi-asserted-by":"crossref","unstructured":"Cao Y, Zhuang M-f, Yang Y, Xie S-w, Cui J-g, Cao L, Zhang T-t, Zhu Y (2014) Preliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model. Evid Based Complement Alternat Med 2014","DOI":"10.1155\/2014\/781684"},{"key":"3347_CR10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3892\/etm.2014.1544","volume":"7","author":"W Chao","year":"2014","unstructured":"Chao W, Xuexin Z, Jun S, Ming C, Hua J, Guofu L, Chunlei T, Wanhai X (2014) Effects of resveratrol on cell growth and prolactin synthesis in GH3 cells. Exp Ther Med 7:923\u2013928","journal-title":"Exp Ther Med"},{"key":"3347_CR11","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2174\/0929867311320160007","volume":"20","author":"CH Chen","year":"2013","unstructured":"Chen CH, Xiao WW, Jiang XB, Wang JW, Mao ZG, Lei N, Fan X, Song BB, Liao CX, Wang HJ, She ZG, Zhu YH (2013) A novel marine drug, SZ-685C, induces apoptosis of MMQ pituitary tumor cells by downregulating miR-200c. Curr Med Chem 20:2145\u20132154","journal-title":"Curr Med Chem"},{"key":"3347_CR12","doi-asserted-by":"crossref","first-page":"E1128","DOI":"10.1210\/jc.2011-3482","volume":"97","author":"D D'Angelo","year":"2012","unstructured":"D'Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A (2012) Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 97:E1128\u2013E1138","journal-title":"J Clin Endocrinol Metab"},{"key":"3347_CR13","doi-asserted-by":"crossref","first-page":"e0117107","DOI":"10.1371\/journal.pone.0117107","volume":"10","author":"J D\u00e9nes","year":"2015","unstructured":"D\u00e9nes J, Kasuki L, Trivellin G, Colli LM, Takiya CM, Stiles CE, Barry S, de Castro M, Gadelha MR, Korbonits M (2015) Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas. PLoS One 10:e0117107","journal-title":"PLoS One"},{"key":"3347_CR14","doi-asserted-by":"crossref","first-page":"e00084","DOI":"10.1128\/MCB.00084-18","volume":"38","author":"SB DeVore","year":"2018","unstructured":"DeVore SB, Young CH, Li G, Sundararajan A, Ramaraj T, Mudge J, Schilkey F, Muth A, Thompson PR, Cherrington BD (2018) Histone citrullination represses microRNA expression, resulting in increased oncogene mRNAs in somatolactotrope cells. Mol Cell Biol 38:e00084\u2013e00018","journal-title":"Mol Cell Biol"},{"key":"3347_CR15","doi-asserted-by":"crossref","first-page":"154442","DOI":"10.1016\/j.prp.2023.154442","volume":"245","author":"AS Doghish","year":"2023","unstructured":"Doghish AS, Hegazy M, Ismail A, El-Mahdy HA, Elsakka EG, Elkhawaga SY, Elkady MA, Yehia AM, Abdelmaksoud NM, Mokhtar MM (2023) A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance. Pathol Res Pract 245:154442","journal-title":"Pathol Res Pract"},{"key":"3347_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/genes9070337","volume":"9","author":"KBV D\u00f8ssing","year":"2018","unstructured":"D\u00f8ssing KBV, Kj\u00e6r C, Vikes\u00e5 J, Binderup T, Knigge U, Culler MD, Kj\u00e6r A, Federspiel B, Friis-Hansen L (2018) Somatostatin analogue treatment primarily induce miRNA expression changes and up-regulates growth inhibitory miR-7 and miR-148a in neuroendocrine cells. Genes 9:337","journal-title":"Genes"},{"key":"3347_CR17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40618-015-0306-7","volume":"38","author":"X Fan","year":"2015","unstructured":"Fan X, Mao Z, He D, Liao C, Jiang X, Lei N, Hu B, Wang X, Li Z, Lin Y, Gou X, Zhu Y, Wang H (2015) Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185. J Endocrinol Invest 38:1117\u20131128","journal-title":"J Endocrinol Invest"},{"key":"3347_CR18","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.3390\/ijms23116075","volume":"23","author":"E Ferrari","year":"2022","unstructured":"Ferrari E, Bettuzzi S, Naponelli V (2022) The potential of epigallocatechin gallate (EGCG) in targeting autophagy for cancer treatment: a narrative review. Int J Mol Sci 23:6075","journal-title":"Int J Mol Sci"},{"key":"3347_CR19","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/en.2012-2070","volume":"154","author":"E Gentilin","year":"2013","unstructured":"Gentilin E, Tagliati F, Filieri C, Mol\u00e8 D, Minoia M, Rosaria Ambrosio M, degli Uberti EC, Zatelli MC (2013) miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase C\u03b4. Endocrinology 154:1690\u20131700","journal-title":"Endocrinology"},{"key":"3347_CR20","doi-asserted-by":"crossref","first-page":"820969","DOI":"10.3389\/fphar.2022.820969","volume":"13","author":"YX Goh","year":"2022","unstructured":"Goh YX, Jalil J, Lam KW, Husain K, Premakumar CM (2022) Genistein: a review on its anti-inflammatory properties. Front Pharmacol 13:820969","journal-title":"Front Pharmacol"},{"key":"3347_CR21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12020-019-01960-7","volume":"65","author":"TM Grzywa","year":"2019","unstructured":"Grzywa TM, Klicka K, Rak B, Mehlich D, Garbicz F, Zieli\u0144ski G, Maksymowicz M, Sajjad E, W\u0142odarski PK (2019) Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN\/AKT, and STAT3 signaling pathways. Endocrine 65:646\u2013655","journal-title":"Endocrine"},{"key":"3347_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainresbull.2019.03.013","volume":"149","author":"B Hu","year":"2019","unstructured":"Hu B, Mao Z, Du Q, Jiang X, Wang Z, Xiao Z, Zhu D, Wang X, Zhu Y, Wang H (2019) miR-93-5p targets Smad7 to regulate the transforming growth factor-\u03b21\/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma. Brain Res Bull 149:21\u201331","journal-title":"Brain Res Bull"},{"key":"3347_CR23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40618-018-0963-4","volume":"42","author":"M Jian","year":"2019","unstructured":"Jian M, Du Q, Zhu D, Mao Z, Wang X, Feng Y, Xiao Z, Wang H, Zhu Y (2019) Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1. J Endocrinol Invest 42:639\u2013652","journal-title":"J Endocrinol Invest"},{"key":"3347_CR24","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/cancers15133375","volume":"15","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Lei Z, Wang Z, Wang Q, Zhang Z, Liu X, Xing B, Li S, Guo X, Liu Y, Li X, Qi Y, Shu K, Zhang H, Huang Y, Lei T (2023) Tumor-associated fibroblast-derived exosomal circDennd1b promotes pituitary adenoma progression by modulating the miR-145-5p\/ONECUT2 axis and activating the MAPK pathway. Cancers 15:3375","journal-title":"Cancers"},{"key":"3347_CR25","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijms18122589","volume":"18","author":"J-H Ko","year":"2017","unstructured":"Ko J-H, Sethi G, Um J-Y, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS (2017) The role of resveratrol in cancer therapy. Int J Mol Sci 18:2589","journal-title":"Int J Mol Sci"},{"key":"3347_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/cells12020306","volume":"12","author":"S Komatsu","year":"2023","unstructured":"Komatsu S, Kitai H, Suzuki HI (2023) Network regulation of microRNA biogenesis and target interaction. Cells 12:306","journal-title":"Cells"},{"key":"3347_CR27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.beem.2016.07.004","volume":"30","author":"J Kr\u00fctzfeldt","year":"2016","unstructured":"Kr\u00fctzfeldt J (2016) Strategies to use microRNAs as therapeutic targets. Best Pract Res Clin Endocrinol Metab 30:551\u2013561","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3347_CR28","unstructured":"Larkin S, Ansorge O (2017) Pathology and pathogenesis of pituitary adenomas and other sellar lesions. Endotext"},{"key":"3347_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/01635581.2018.1446090","volume":"70","author":"CT Le","year":"2018","unstructured":"Le CT, Leenders WP, Molenaar RJ, van Noorden CJ (2018) Effects of the green tea polyphenol epigallocatechin-3-gallate on glioma: a critical evaluation of the literature. Nutr Cancer 70:317\u2013333","journal-title":"Nutr Cancer"},{"key":"3347_CR30","first-page":"4651","volume":"18","author":"B Li","year":"2019","unstructured":"Li B, Zhu HB, Song GD, Cheng JH, Li CZ, Zhang YZ, Zhao P (2019) Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition. Oncol Lett 18:4651\u20134658","journal-title":"Oncol Lett"},{"key":"3347_CR31","doi-asserted-by":"crossref","first-page":"29413","DOI":"10.18632\/oncotarget.5003","volume":"6","author":"HQ Liang","year":"2015","unstructured":"Liang HQ, Wang RJ, Diao CF, Li JW, Su JL, Zhang S (2015) The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53\/PTTG1 regulation feedback loop. Oncotarget 6:29413\u201329427","journal-title":"Oncotarget"},{"key":"3347_CR32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41598-017-00409-z","volume":"7","author":"C-M Lin","year":"2017","unstructured":"Lin C-M, Chen H-H, Lin C-A, Wu H-C, Sheu JJ-C, Chen H-J (2017) Apigenin-induced lysosomal degradation of \u03b2-catenin in Wnt\/\u03b2-catenin signaling. Sci Rep 7:372","journal-title":"Sci Rep"},{"key":"3347_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/JOE-18-0278","volume":"240","author":"KE Lines","year":"2019","unstructured":"Lines KE, Newey PJ, Yates CJ, Stevenson M, Dyar R, Walls GV, Bowl MR, Thakker RV (2019) miR-15a\/miR-16-1 expression inversely correlates with cyclin D1 levels in Men1 pituitary NETs. J Endocrinol 240:41\u201350","journal-title":"J Endocrinol"},{"key":"3347_CR34","doi-asserted-by":"crossref","first-page":"1077531","DOI":"10.3389\/fimmu.2023.1077531","volume":"14","author":"N Lotfi","year":"2023","unstructured":"Lotfi N, Yousefi Z, Golabi M, Khalilian P, Ghezelbash B, Montazeri M, Shams MH, Baghbadorani PZ, Eskandari N (2023) The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: an update. Front Immunol 14:1077531","journal-title":"Front Immunol"},{"key":"3347_CR35","doi-asserted-by":"crossref","unstructured":"Manso J, Sharifi-Rad J, Zam W, Tsouh Fokou PV, Martorell M, Pezzani R (2021) Plant natural compounds in the treatment of adrenocortical tumors. Int J Endocrinol 2021","DOI":"10.1155\/2021\/5516285"},{"key":"3347_CR36","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.3390\/ijms241310737","volume":"24","author":"V Mar\u00edn","year":"2023","unstructured":"Mar\u00edn V, Burgos V, P\u00e9rez R, Maria DA, Pardi P, Paz C (2023) The potential role of epigallocatechin-3-gallate (EGCG) in breast cancer treatment. Int J Mol Sci 24:10737","journal-title":"Int J Mol Sci"},{"key":"3347_CR37","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/en.2007-1760","volume":"149","author":"M Miller","year":"2008","unstructured":"Miller M, Chen S, Woodliff J, Kansra S (2008) Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology 149:4158\u20134167","journal-title":"Endocrinology"},{"key":"3347_CR38","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ph16111631","volume":"16","author":"MA Mirza","year":"2023","unstructured":"Mirza MA, Mahmood S, Hilles AR, Ali A, Khan MZ, Zaidi SAA, Iqbal Z, Ge Y (2023) Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications\u2014a review. Pharmaceuticals 16:1631","journal-title":"Pharmaceuticals"},{"key":"3347_CR39","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.3390\/ijms23052867","volume":"23","author":"BJ Mossakowska","year":"2022","unstructured":"Mossakowska BJ, Kober P, Rusetska N, Boresowicz J, Maksymowicz M, P\u0119kul M, Zieli\u0144ski G, Styk A, Kunicki J, Mandat T, Bujko M (2022) Difference in miRNA expression in functioning and silent corticotroph pituitary adenomas indicates the role of miRNA in the regulation of corticosteroid receptors. Int J Mol Sci 23:2867","journal-title":"Int J Mol Sci"},{"key":"3347_CR40","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1080\/15384101.2015.1064207","volume":"14","author":"P M\u00fcssnich","year":"2015","unstructured":"M\u00fcssnich P, Raverot G, Jaffrain-Rea M-L, Fraggetta F, Wierinckx A, Trouillas J, Fusco A, D'Angelo D (2015) Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors. Cell Cycle 14:2590\u20132597","journal-title":"Cell Cycle"},{"key":"3347_CR41","doi-asserted-by":"crossref","unstructured":"Nikolova E, Nankova A, Kalenderova S, Georgieva B, Hadzhiyanev A, Bichev S, Savov A, Todorova A, Mitev V, Elenkova A (2024) MiRNA signatures related to invasiveness and recurrence in patients with non-functioning pituitary neuroendocrine tumors. Exp Clin Endocrinol Diabetes","DOI":"10.1055\/a-2268-4129"},{"key":"3347_CR42","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/onc.2012.190","volume":"32","author":"T Palumbo","year":"2013","unstructured":"Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA (2013) Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN\u2013AKT pathway. Oncogene 32:1651\u20131659","journal-title":"Oncogene"},{"key":"3347_CR43","doi-asserted-by":"crossref","first-page":"204201882110585","DOI":"10.1177\/20420188211058583","volume":"13","author":"A Pence","year":"2022","unstructured":"Pence A, McGrath M, Lee SL, Raines DE (2022) Pharmacological management of severe Cushing\u2019s syndrome: the role of etomidate. Ther Adv Endocrinol Metab 13:20420188211058583","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3347_CR44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BM, Bronstein M, Chanson P, Fukuoka H, Gadelha M (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement. Nat Rev Endocrinol 19:722\u2013740","journal-title":"Nat Rev Endocrinol"},{"key":"3347_CR45","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.3390\/molecules27186051","volume":"27","author":"AH Rahmani","year":"2022","unstructured":"Rahmani AH, Alsahli MA, Almatroudi A, Almogbel MA, Khan AA, Anwar S, Almatroodi SA (2022) The potential role of apigenin in cancer prevention and treatment. Molecules 27:6051","journal-title":"Molecules"},{"key":"3347_CR46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330:170\u2013181","journal-title":"JAMA"},{"key":"3347_CR47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.canlet.2014.10.003","volume":"356","author":"W Renjie","year":"2015","unstructured":"Renjie W, Haiqian L (2015) MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5. Cancer Lett 356:568\u2013578","journal-title":"Cancer Lett"},{"key":"3347_CR48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmed.2015.00054","volume":"2","author":"M Roche","year":"2015","unstructured":"Roche M, Wierinckx A, Croze S, Rey C, Legras-Lachuer C, Morel A-P, Fusco A, Raverot G, Trouillas J, Lachuer J (2015) Deregulation of miR-183 and KIAA0101 in aggressive and malignant pituitary tumors. Front Med 2:54","journal-title":"Front Med"},{"key":"3347_CR49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfh257","volume":"82","author":"JT Sanderson","year":"2004","unstructured":"Sanderson JT, Hordijk J, Denison MS, Springsteel MF, Nantz MH, Van Den Berg M (2004) Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci 82:70\u201379","journal-title":"Toxicol Sci"},{"key":"3347_CR50","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1677\/ERC-09-0129","volume":"16","author":"C Schaaf","year":"2009","unstructured":"Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, Stalla G, Schilling T, Arzt E, Perone M (2009) Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer 16:1339\u20131350","journal-title":"Endocr Relat Cancer"},{"key":"3347_CR51","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R, Lee S, Senavirathne G, Lai EC (2023) microRNAs in action: biogenesis, function and regulation. Nat Rev Genet 24:816\u2013833","journal-title":"Nat Rev Genet"},{"key":"3347_CR52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/09168451.2019.1591260","volume":"83","author":"DW Shen","year":"2019","unstructured":"Shen DW, Li YL, Hou YJ, Xu ZD, Li YZ, Chang JY (2019) MicroRNA-543 promotes cell invasion and impedes apoptosis in pituitary adenoma via activating the Wnt\/\u03b2-catenin pathway by negative regulation of Smad7. Biosci Biotechnol Biochem 83:1035\u20131044","journal-title":"Biosci Biotechnol Biochem"},{"key":"3347_CR53","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","volume":"26","author":"Z-J Song","year":"2016","unstructured":"Song Z-J, Reitman ZJ, Ma Z-Y, Chen J-H, Zhang Q-L, Shou X-F, Huang C-X, Wang Y-F, Li S-Q, Mao Y (2016) The genome-wide mutational landscape of pituitary adenomas. Cell Res 26:1255\u20131259","journal-title":"Cell Res"},{"key":"3347_CR54","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.21037\/gs-21-720","volume":"10","author":"B Sun","year":"2021","unstructured":"Sun B, Dai C, Zhao S, Dong H, Liu H, Li Y, Wang R, Kang JJGS (2021) MicroRNA-30d target TIMP3 induces pituitary tumor cell growth and invasion. Gland Surg 10:3314\u20133323","journal-title":"Gland Surg"},{"key":"3347_CR55","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/molecules29061373","volume":"29","author":"WH Talib","year":"2024","unstructured":"Talib WH, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M, Aa AS, Abu Asab S, Hadi RW, Al Kury LT (2024) Targeting cancer hallmarks with epigallocatechin gallate (EGCG): mechanistic basis and therapeutic targets. Molecules 29:1373","journal-title":"Molecules"},{"key":"3347_CR56","first-page":"135","volume":"50","author":"E Tu\u0161imov\u00e1","year":"2017","unstructured":"Tu\u0161imov\u00e1 E, Packov\u00e1 D, Kov\u00e1\u010dik A, Ondru\u0161ka \u013d, Koles\u00e1rov\u00e1 A (2017) Possible stimulatory effect of quercetin on secretion of selected pituitary hormones. Scient Pap Anim Sci Biotechnol 50:135\u2013135","journal-title":"Scient Pap Anim Sci Biotechnol"},{"key":"3347_CR57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnut.2016.00008","volume":"3","author":"EM Varoni","year":"2016","unstructured":"Varoni EM, Lo Faro AF, Sharifi-Rad J, Iriti M (2016) Anticancer molecular mechanisms of resveratrol. Front Nutr 3:8","journal-title":"Front Nutr"},{"key":"3347_CR58","doi-asserted-by":"crossref","unstructured":"Voellger B, Kirches E, Wilisch-Neumann A, Weise A, Tapia-Perez H, Rupa R, Mawrin C, Firsching R (2013) Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat. OncoTargets Ther:1269\u20131276","DOI":"10.2147\/OTT.S45154"},{"key":"3347_CR59","doi-asserted-by":"crossref","unstructured":"Wang DS, Zhang HQ, Zhang B, Yuan ZB, Yu ZK, Yang T, Zhang SQ, Liu Y, Jia XX (2016) miR-133 inhibits pituitary tumor cell migration and invasion via down-regulating FOXC1 expression. Genet Mol Res 15","DOI":"10.4238\/gmr.15017453"},{"key":"3347_CR60","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/cancers15051624","volume":"15","author":"Q Wang","year":"2023","unstructured":"Wang Q, Lei Z, Wang Z, Jiang Q, Zhang Z, Liu X, Xing B, Li S, Guo X, Liu Y (2023) PKC\u03b8 regulates pituitary adenoma bone invasion by activating osteoclast in NF-\u03baB\/IL-1\u03b2-dependent manner. Cancers 15:1624","journal-title":"Cancers"},{"key":"3347_CR61","doi-asserted-by":"crossref","first-page":"45874","DOI":"10.18632\/oncotarget.17437","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Du Q, Mao Z, Fan X, Hu B, Wang Z, Chen Z, Jiang X, Wang Z, Lei N, Wang H, Zhu Y (2017) Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines. Oncotarget 8:45874\u201345887","journal-title":"Oncotarget"},{"key":"3347_CR62","doi-asserted-by":"crossref","first-page":"566761","DOI":"10.3389\/fendo.2020.566761","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang X, Fang Y, Zhou Y, Guo X, Xu K, Li C, Zhang J, Hong Y (2020) SDF-1\u03b1\/microRNA-134 axis regulates nonfunctioning pituitary neuroendocrine tumor growth via targeting VEGFA. Front Endocrinol 11:566761","journal-title":"Front Endocrinol"},{"key":"3347_CR63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcp.10244","volume":"195","author":"SN Wu","year":"2003","unstructured":"Wu SN, Chiang HT, Shen AY, Lo YK (2003) Differential effects of quercetin, a natural polyphenolic flavonoid, on L-type calcium current in pituitary tumor (GH3) cells and neuronal NG108-15 cells. J Cell Physiol 195:298\u2013308","journal-title":"J Cell Physiol"},{"key":"3347_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-18-0203","volume":"240","author":"Z Wu","year":"2019","unstructured":"Wu Z, Cai L, Lu J, Wang C, Guan J, Chen X, Wu J, Zheng W, Wu Z, Li Q, Su Z (2019) MicroRNA-93 mediates cabergoline resistance by targeting ATG7 in prolactinoma. J Endocrinol 240:1\u201313","journal-title":"J Endocrinol"},{"key":"3347_CR65","doi-asserted-by":"crossref","first-page":"111033","DOI":"10.1016\/j.mce.2020.111033","volume":"518","author":"Z Wu","year":"2020","unstructured":"Wu Z, Zheng Y, Xie W, Li Q, Zhang Y, Ren B, Cai L, Cheng Y, Tang H, Su Z, Wu ZB (2020) The long noncoding RNA-H19\/miRNA-93a\/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists. Mol Cell Endocrinol 518:111033","journal-title":"Mol Cell Endocrinol"},{"key":"3347_CR66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2014.07.014","volume":"395","author":"ZB Wu","year":"2014","unstructured":"Wu ZB, Li WQ, Lin SJ, Wang CD, Cai L, Lu JL, Chen YX, Su ZP, Shang HB, Yang WL, Zhao WG (2014) MicroRNA expression profile of bromocriptine-resistant prolactinomas. Mol Cell Endocrinol 395:10\u201318","journal-title":"Mol Cell Endocrinol"},{"key":"3347_CR67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yexcr.2018.01.008","volume":"367","author":"W Yang","year":"2018","unstructured":"Yang W, Xu T, Qiu P, Xu G (2018) Caveolin-1 promotes pituitary adenoma cells migration and invasion by regulating the interaction between EGR1 and KLF5. Exp Cell Res 367:7\u201314","journal-title":"Exp Cell Res"},{"key":"3347_CR68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2009.01.003","volume":"302","author":"L Ye","year":"2009","unstructured":"Ye L, Chan MY, Leung LK (2009) The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Mol Cell Endocrinol 302:73\u201380","journal-title":"Mol Cell Endocrinol"},{"key":"3347_CR69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/neuonc\/3.1.22","volume":"3","author":"S Yokoyama","year":"2001","unstructured":"Yokoyama S, Hirano H, Wakimaru N, Sarker KP, Kuratsu J-i (2001) Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro. Neuro-oncology 3:22\u201328","journal-title":"Neuro-oncology"},{"key":"3347_CR70","doi-asserted-by":"crossref","first-page":"154437","DOI":"10.1016\/j.prp.2023.154437","volume":"245","author":"MB Zaki","year":"2023","unstructured":"Zaki MB, Abulsoud AI, Elshaer SS, Fathi D, Abdelmaksoud NM, El-Mahdy HA, Ismail A, Elsakka EG, Sallam A-AM, Doghish AS (2023) The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy. Pathol Res Pract 245:154437","journal-title":"Pathol Res Pract"},{"key":"3347_CR71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/978-2-88963-602-0","volume-title":"Molecular network study of pituitary adenomas","author":"X Zhan","year":"2020","unstructured":"Zhan X, Desiderio DM (2020) Molecular network study of pituitary adenomas. Frontiers Media SA, p 26"},{"key":"3347_CR72","first-page":"10969","volume":"10","author":"J Zhang","year":"2017","unstructured":"Zhang J, Ma D, Liu H, Wang J, Fan J, Li X (2017) MicroRNA-143 shows tumor suppressive effects through inhibition of oncogenic K-Ras in pituitary tumor. Int J Clin Exp Pathol 10:10969\u201310978","journal-title":"Int J Clin Exp Pathol"},{"key":"3347_CR73","doi-asserted-by":"crossref","first-page":"34718","DOI":"10.1074\/jbc.M110.126441","volume":"285","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Florez S, Gutierrez-Hartmann A, Martin JF, Amendt BA (2010) MicroRNAs Regulate Pituitary Development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression. J Biol Chem 285:34718\u201334728","journal-title":"J Biol Chem"},{"key":"3347_CR74","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0043-106437","volume":"49","author":"W Zhen","year":"2017","unstructured":"Zhen W, Qiu D, Zhiyong C, Xin W, Mengyao J, Dimin Z, Chonghui H, Haijun W, Yonghong Z (2017) MicroRNA-524-5p functions as a tumor suppressor in a human pituitary tumor-derived cell line. Horm Metab Res 49:550\u2013557","journal-title":"Horm Metab Res"},{"key":"3347_CR75","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.12659\/MSM.900092","volume":"23","author":"Z Zheng","year":"2017","unstructured":"Zheng Z, Zhang Y, Zhang Z, Yang Y, Song T (2017) Effect of miR-106b on invasiveness of pituitary adenoma via PTEN-PI3K\/AKT. Med Sci Monit 23:1277\u20131285","journal-title":"Med Sci Monit"},{"key":"3347_CR76","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/OTT.S118391","volume":"10","author":"K Zhou","year":"2017","unstructured":"Zhou K, Fan YD, Wu PF, Duysenbi S, Feng ZH, Du GJ, Zhang TR (2017) MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro. Onco Targets Ther 10:1625\u20131635","journal-title":"Onco Targets Ther"},{"key":"3347_CR77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3171\/2019.10.JNS191959","volume":"134","author":"D Zhu","year":"2021","unstructured":"Zhu D, Xiao Z, Wang Z, Hu B, Duan C, Zhu Z, Gao N, Zhu Y, Wang H (2021) MEG3\/MIR-376B-3P\/HMGA2 axis is involved in pituitary tumor invasiveness. J Neurosurg 134:499\u2013511","journal-title":"J Neurosurg"},{"key":"3347_CR78","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/chem-2018-0080","volume":"16","author":"W Zhuang","year":"2018","unstructured":"Zhuang W, Qian L, Fei W, Xiaolei L, Jing G, Bing L, Hongyun W, Hua G, Yazhuo Z (2018) The role of NR2C2 in the prolactinomas. NR2C2 targeted by miR-129-5p in prolactinomas. Open Chem 16:817\u2013826","journal-title":"Open Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03347-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03347-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T09:04:19Z","timestamp":1738400659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03347-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03347-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}